J. J. O'byrne, M. Tarailo-graovac, A. Ghani, M. Champion, C. Deshpande et al., The genotypic and phenotypic spectrum of MTO1 deficiency, Mol. Genet. Metab, vol.123, pp.28-42, 2018.

J. Finsterer and S. Z. Mahjoub, Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders, Expert Opin. Drug Metab. Toxicol, vol.8, pp.71-79, 2012.

J. Hynynen, T. Komulainen, E. Tukiainen, A. Nordin, J. Arola et al., Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation, Liver Transpl, vol.20, pp.1402-1412, 2014.

I. Siddiq, E. Widjaja, and I. Tein, Clinical and radiologic reversal of stroke-like episodes in MELAS with high-dose L-arginine, Neurology, vol.85, pp.197-198, 2015.

J. Finsterer, Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction, Pediatr. Cardiol, vol.30, pp.659-681, 2009.